-
1 Comment
Pharmasimple SA is currently in a long term downtrend where the price is trading 18.7% below its 200 day moving average.
From a valuation standpoint, the stock is 82.6% cheaper than other stocks from the Consumer Cyclical sector with a price to sales ratio of 0.5.
Based on the above factors, Pharmasimple SA gets an overall score of 1/5.
ISIN | BE0974302342 |
---|---|
Sector | Consumer Cyclical |
Industry | Internet Retail |
Exchange | PA |
CurrencyCode | EUR |
Market Cap | 2K |
---|---|
PE Ratio | None |
Target Price | 9.8 |
Beta | 1.21 |
Dividend Yield | None |
Pharmasimple SA operates a Website for medicines, cosmetics, and food supplements in Belgium and France. It offers face products comprising accessories, creams, cleansers, scrubs, masks, supplements, tanners, and other care products; body and hair, makeup, solar, and products; waters and perfumes; food supplements; health accessories, bandages, devices, first-aid, and pain/ache, as well as diet products; and masks, thermometers, glover, air purifiers, and home and hand hygiene products. The company also provides toilet, and mom and baby care; sliming and sports products; daily, oral, and organic hygiene products; and aromatherapy, bach flowers, homeopathy, apitherapy, herbalism, phytotherapy, gemmotherapy, floral elixirs, balneotherapy, light therapy, lithotherapy, and magnetotherapy medicines; as well as male, animals, and organic and natural products. Pharmasimple SA was founded in 2010 and is based in Houdeng-Goegnies, Belgium.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALPHS.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025